G. Al-Atrash

Fludarabine with Myeloablative Timed-Sequential Busulfan in Older Patients: Results of a Randomized Phase II Clinical Trial

K. Rezvani, D. Marin, S. Parmar, 2019 .

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial.

K. Rezvani, D. Marin, S. Parmar, 2018, The Lancet. Haematology.